The National Cancer Institute is offering this grant to integrate biospecimen science into clinical assay development.
SynopsisVersion HistoryRelated DocumentsPackage The National Cancer Institute (NCI) is offering this grant to support extramural research aimed at overcoming challenges in clinical assay development. This grant is for investigating how preanalytical variability in biospecimens, such as tumor tissue biopsies, blood (liquid biopsies), and other bodily fluids, impacts emerging biomarker quantification. Investigator-designed experiments will explore the effects of different biospecimen collection, processing, and storage conditions on various testing platforms. The overall goal [...]